Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5‐hydroxtryptamine system
Open accessAbstract
The aim of the present study was to investigate the putative modulation of locus coeruleus (LC) noradrenergic (NA) neurones by the 5‐hydroxytryptaminergic (5‐HT) system by use of in vivo extracellular unitary recordings and microiontophoresis in anaesthetized rats. To this end, the potent and selective 5‐HT 1A receptor antagonist WAY 100635 (N‐{2‐[4(2‐methoxyphenyl)‐1‐piperazinyl]ethyl}‐N‐(2‐pyridinyl)cyclohexanecarboxamide trihydroxychloride) was used. In the dorsal hippocampus, both local (by microiontophoresis, 20 nA) and systemic (100 μg kg−1, i.v.) administration of WAY 100635 antagonized the suppressant effect of microiontophorectically‐applied 5‐HT on the firing activity of CA 3 pyramidal neurones, indicating its antagonistic effect on postsynaptic 5‐HT 1A receptors. WAY 100635 and 5‐HT failed to modify the spontaneous firing activity of LC NA neurones when applied by microiontophoresis. However, the intravenous injection of WAY 100635 (100 μg kg−1) readily suppressed the spontaneous firing activity of LC NA neurones. The lesion of 5‐HT neurones with the neurotoxin 5,7‐dihydroxytryptamine increased the spontaneous firing activity of LC NA neurones and abolished the suppressant effect of WAY 100635 on the firing activity of LC NA neurones. In order to determine the nature of the 5‐HT receptor subtypes mediating the suppressant effect of WAY 100635 on NA neurone firing activity, several 5‐HT receptor antagonists were used. The selective 5‐HT 3 receptor antagonist BRL 46470A (10 and 100 μg kg−1, i.v.), the 5‐HT 1D receptor antagonist GR 127935 (100 μg kg−1, i.v.) and the 5‐HT 1A/1B receptor antagonist (−)‐pindolol (15 mg kg−1, i.p.) did not prevent the suppressant effect of WAY 100635 on the firing activity of LC NA neurones. However, the suppressant effect of WAY 100635 was prevented by the non‐selective 5‐HT receptor antagonists spiperone (1 mg kg−1, i.v.) and metergoline (1 mg kg−1, i.v.), by the 5‐HT 2 receptor antagonist ritanserin (500 μg kg−1, i.v.). It was also prevented by the 5‐HT 1A receptor/α 1D‐adrenoceptor antagonist BMY 7378 (1 mg kg−1, i.v.) and by the α 1‐adrenoceptor antagonist prazosin (100 μg kg−1, i.v.). These data support the notion that the 5‐HT system tonically modulates NA neurotransmission since the lesion of 5‐HT neurones enhanced the LC NA neurones firing activity and the suppressant effect of WAY 100635 on the firing activity of NA neurones was abolished by this lesion. However, the location of the 5‐HT 1A receptors involved in this complex circuitry remains to be elucidated. It is concluded that the suppressant effect of WAY 100635 on the firing activity of LC NA neurones is due to an enhancement of the function of 5‐HT neurones via a presynaptic 5‐HT 1A receptor. In contrast, the postsynaptic 5‐HT receptor mediating this effect of WAY 100635 on NA neurones appears to be of the 5‐HT 2A subtype. British Journal of Pharmacology (1997) 120, 865–875; doi:10.1038/sj.bjp.0700968
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Long-term use of SSRIs can increase 5-HT transmission in the LC, thereby increasing the release of GABA to exert inhibitory effects on NA neurons.
“Third, long-term use of SSRIs can increase 5-HT transmission in the LC, 362 thereby increasing the release of GABA to exert inhibitory effects on NA neurons. 363”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [362]
The Discussion (page unavailable) reports tonic inhibition of rat LC noradrenergic neurons by the 5-HT system. The Introduction (page unavailable) describes increased GABA inhibitory input as a proposed explanation for the effect of a 5-HT2 agonist. Neither passage establishes that long-term SSRI use increases 5-HT transmission in the LC or GABA release. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 2,997 · see citing works
Svensson, T. H., Bunney, B. S., & Aghajanian, G. K. (1975) · Brain Research · doi:10.1016/0006-8993(75)90276-0 · Cited by 1,009 · see citing works
Jones, B. E., & Yang, T. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902420105 · Cited by 896 · see citing works
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870 · see citing works
Paxinos, G., & WATSON, C. R. R. (1982) · Elsevier eBooks · doi:10.1016/b978-0-12-547620-1.50007-2 · Cited by 824 · see citing works
ELECTROPHYSIOLOGY OF HIPPOCAMPAL NEURONS: II. AFTER-POTENTIALS AND REPETITIVE FIRING
Kandel, E. R., & Spencer, W. A. (1961) · Journal of Neurophysiology · doi:10.1152/jn.1961.24.3.243 · Cited by 694 · see citing works
Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., Foye, P. E., Racke, M. M., Slone, A. L., Siegel, B. W., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90149-l · Cited by 691 · see citing works
Ruat, M., Traiffort, É., Leurs, R., Tardivel‐Lacombe, J., Díaz, J., Arrang, J., & Schwartz, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 617 · see citing works
A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635
Forster, E. A., Cliffe, I. A., Bill, D. J., Dover, G. M., Jones, D., Reilly, Y., & Fletcher, A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00234-c · Cited by 614 · see citing works
Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique
Cedarbaum, J. M., & Aghajanian, G. K. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901780102 · Cited by 549 · see citing works
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain
Wright, D. E., Seroogy, K. B., Lundgren, K. H., Davis, B. M., & Jennes, L. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510304 · Cited by 548 · see citing works
Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology
Aston‐Jones, G., Shipley, M., Chouvet, G., Ennis, M. J., Bockstaele, E. V., Pieribone, V. A., Shiekhattar, R., Akaoka, H., Drolet, G., Astier, B., et al. (1991) · Progress in brain research · doi:10.1016/s0079-6123(08)63799-1 · Cited by 543 · see citing works
Fletcher, A., Forster, E. A., Bill, D. J., Brown, G., Cliffe, I. A., Hartley, J. E., Jones, D. E., McLenachan, A. P., Stanhope, K. J., Critchley, D. J. P., et al. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00118-0 · Cited by 526 · see citing works
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Shen, Y., Monsma, F. J., Metcalf, M. A., José, P. A., Hamblin, M. W., & Sibley, D. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46830-x · Cited by 508 · see citing works
Griebel, G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98597-j · Cited by 487 · see citing works
Leysen, J. E., Gommeren, W., Gompel, P. V., Wynants, J., Janssen, P. F. M., & Laduron, P. M. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12558-3 · Cited by 452 · see citing works
Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists
Baraban, J. M., & Aghajanian, G. K. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90187-2 · Cited by 442 · see citing works
Blier, P. U., & de Montigny, C. (1987) · Synapse · doi:10.1002/syn.890010511 · Cited by 426 · see citing works
Self-citation5-HT2 receptor subtypes: A family re-united?
Baxter, G. S., Kennett, G. A., Blackburn, T. P., et al. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88991-9 · Cited by 346 · see citing works
Luppi, P., Aston‐Jones, G., Akaoka, H., Chouvet, G., & Jouvet, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00481-j · Cited by 344 · see citing works
Projections of the nucleus locus coeruleus in the albino rat
Loizou, L. A. (1969) · Brain Research · doi:10.1016/0006-8993(69)90185-1 · Cited by 340 · see citing works
Gartside, S. E., Umbers, V., Hajós, M., & Sharp, T. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15919.x · Cited by 311 · see citing works
BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors
Goetz, A. S., King, H. K., Ward, S. D. C., et al. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00751-r · Cited by 301 · see citing works
Pickel, V. M., JOH, T. H., & Reis, D. J. (1977) · Brain Research · doi:10.1016/0006-8993(77)90515-7 · Cited by 274 · see citing works
Baraban, J. M., & Aghajanian, G. K. (1981) · Brain Research · doi:10.1016/0006-8993(81)90646-6 · Cited by 259 · see citing works
Segal, M. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012628 · Cited by 247 · see citing works
Projections of the dorsal raphe nucleus to the brainstem: PHA‐L analysis in the rat
Vertes, R. P., & Kocsis, B. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903400103 · Cited by 198 · see citing works
Romero, L. I. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00240-e · Cited by 185 · see citing works
GOZLAN, H., Thibault, S., Laporte, A., et al. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90192-2 · Cited by 182 · see citing works
Aston‐Jones, G., Akaoka, H., Charléty, P. J., & Chouvet, G. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00760.1991 · Cited by 181 · see citing works
Desensitization of the neuronal 5-HT carrier following its long-term blockade
Piñeyro, G., Blier, P., Dennis, T., & de Montigny, C. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03036.1994 · Cited by 179 · see citing works
Self-citationMarwaha, J., & Aghajanian, G. K. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33193-9 · Cited by 164 · see citing works
Serotonin nerve terminals in the locus coeruleus of adult rat: A radioautographic study
Léger, L., & Descarries, L. (1978) · Brain Research · doi:10.1016/0006-8993(78)90791-6 · Cited by 163 · see citing works
Ranck, J. B. (1975) · Springer eBooks · doi:10.1007/978-1-4684-2979-4_7 · Cited by 162 · see citing works
Fuxé, K., Agnati, L. F., & Everitt, B. J. (1975) · Neuroscience Letters · doi:10.1016/0304-3940(75)90044-0 · Cited by 158 · see citing works
Davidson, C., & Stamford, J. A. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13321.x · Cited by 157 · see citing works
Fischette, C. T., Nock, B. L., & Renner, K. J. (1987) · Brain Research · doi:10.1016/0006-8993(87)91296-0 · Cited by 153 · see citing works
Fiorella, D. J., Rabin, R. A., & Winter, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246074 · Cited by 137 · see citing works
Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies.
Aghajanian, G. K. (1978) · PubMed · Cited by 132 · see citing works
Haddjeri, N., Blier, P. U., & de Montigny, C. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12944-3 · Cited by 124 · see citing works
Self-citationElectrophysiology of the Central Serotonin System: Receptor Subtypes and Transducer Mechanismsa
Aghajanian, G. K., Sprouse, J. S., Sheldon, P. W., & Rasmussen, K. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16875.x · Cited by 117 · see citing works
Chaput, Y., & de Montigny, C. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21028-x · Cited by 107 · see citing works
Bobker, D. H., & Williams, J. T. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21386-6 · Cited by 107 · see citing works
Rasmussen, K., & Aghajanian, G. K. (1986) · Brain Research · doi:10.1016/0006-8993(86)91090-5 · Cited by 103 · see citing works
Khawaja, X. Z., Evans, N. M., Reilly, Y., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062716.x · Cited by 99 · see citing works
Sanghera, M. K., McMillen, B. A., & German, D. C. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90406-x · Cited by 98 · see citing works
Gorea, E., & Adrien, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90203-8 · Cited by 91 · see citing works
Cox, R. F., Meller, E., & Waszczak, B. L. (1993) · Synapse · doi:10.1002/syn.890140407 · Cited by 87 · see citing works
Chiang, C., & Aston‐Jones, G. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90262-e · Cited by 80 · see citing works
In vivo regulation of the serotonin-2 receptor in rat brain
Stockmeier, C. A., & Kellar, K. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90003-2 · Cited by 73 · see citing works
Kawahara, F., Saitō, H., & Katsuki, H. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020230 · Cited by 72 · see citing works
Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices.
Blandina, P., Goldfarb, J., Walcott, J., et al. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23184-6 · Cited by 69 · see citing works
Hjorth, S., Bengtsson, H. J., Milano, S. P., et al. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00038-8 · Cited by 66 · see citing works
McRae‐Degueurce, A., Bérod, A., Mermet, A., et al. (1982) · Brain Research · doi:10.1016/0006-8993(82)91008-3 · Cited by 66 · see citing works
Evidence that 5‐HT2receptor activation decreases noradrenaline release in rat hippocampusin vivo
Done, C., & Sharp, T. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14493.x · Cited by 66 · see citing works
Essays in neurochemistry and neuropharmacology
Blaschko, H. K. F. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90138-5 · Cited by 65 · see citing works
Matsumoto, M., Yoshioka, M., Togashi, H., Tochihara, M., Ikeda, T., & SAITO, H. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24527-x · Cited by 61 · see citing works
Crespi, F., Buda, M., McRae‐Degueurce, A., et al. (1980) · Brain Research · doi:10.1016/0006-8993(80)91298-6 · Cited by 59 · see citing works
Mongeau, R., de Montigny, C., & Blier, P. U. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90552-5 · Cited by 55 · see citing works
Self-citationClement, H. ‐., Gemsa, D., & Wesemann, W. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245033 · Cited by 54 · see citing works
Locus coeruleus-to-dorsal raphe input examined by electrophysiological and morphological methods
Anderson, C. D., Pasquier, D. A., Forbes, W. B., et al. (1977) · Brain Research Bulletin · doi:10.1016/0361-9230(77)90040-5 · Cited by 54 · see citing works
WAY-100635 and GR127935: Effects on 5-hydroxytryptamine-containing neurones
Craven, R., Grahame‐Smith, D. G., & Newberry, N. R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90289-5 · Cited by 53 · see citing works
Effects ofp-chlorophenylalanine on cortical monoamines and on the activity of noradrenergic neurons
Reader, T. A., Bri�re, R., Grondin, L., & Ferron, A. (1986) · Neurochemical Research · doi:10.1007/bf00965591 · Cited by 52 · see citing works
BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors
Newberry, N. R., Watkins, C. S., Sprosen, T. S., Blackburn, T. P., GRAHAMESMITH, D., & Leslie, R. A. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90180-b · Cited by 50 · see citing works
Maeda, T., Kojima, Y., Arai, R., Fujimiya, M., Kimura, H., Kitahama, K., & Geffard, M. (1991) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(91)90195-y · Cited by 49 · see citing works
Bosker, F. J., Winter, T. Y. C. E. D., Klompmakers, A. A., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062546.x · Cited by 44 · see citing works
Akaoka, H., Charléty, P. J., Saunier, C. F., Buda, M., & Chouvet, G. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90364-8 · Cited by 39 · see citing works
Leysen, J. E., Geerts, R., Gommeren, W., Verwimp, M., & Gompel, P. V. (1982) · PubMed · Cited by 35 · see citing works
Gurling, J., Ashworth-Preece, M. A., Dourish, C. T., et al. (1994) · British Journal of Pharmacology · Cited by 32 · see citing works
Welsh, N. J., Shankley, N. P., & Black, J. W. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13035.x · Cited by 31 · see citing works
α2-Adrenoceptor modulation of 5-HT biosynthesis in the rat brain
Yoshioka, M., Matsumoto, M., Togashi, H., et al. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90856-3 · Cited by 30 · see citing works
Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity
Sanghera, M. K., Coke, J. A., Williams, H. L., et al. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90284-7 · Cited by 23 · see citing works
Citalopram and 8-OH-DPAT attenuate nicotine-induced excitation of central noradrenaline neurons
Engberg, G. (1992) · Journal of Neural Transmission · doi:10.1007/bf01250667 · Cited by 18 · see citing works
Fornal, C. A., Metzler‐Baddeley, C., Veasey, S. C., et al. (1994) · British Journal of Pharmacology · Cited by 16 · see citing works
Zgombick, J. M., Adham, N., Bard, J., et al. (1995) · The Society for Neuroscience Abstracts · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Youdim, M.B.H., Lovenberg, W., Sharman, D.F., Lagnado, J.R. pp. 2 ± 32. New York: J. Wiley & Sons.
- Isaacson, R.L. & Pribram, K.H. pp. 207 ± 244. New York: Plenum.
Cited by
Sorted by citations
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · see citing works
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,061 · see citing works
“453 The NA/NE system, especially in the LC, is another monoaminergic system that exhibits sex-related variations and in fl uences MDD risk.”
BackgroundPehrson, A. L., Cremers, T., Bétry, C., van der Hart, M. G. C., Jørgensen, L., Madsen, M., Haddjeri, N., Ebert, B., & Sanchez, C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.006 · Cited by 155 · see citing works
Self-citationModulation of noradrenergic neuronal firing by selective serotonin reuptake blockers
Szabo, S. T., De Montigny, C., & Blier, P. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702343 · Cited by 114 · see citing works
Self-citationBailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89 · see citing works
Lopez-Alvarez, V. M., Puigdomenech, M., Navarro, X., & Cobianchi, S. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.007 · Cited by 59 · see citing works
- Authors
- Haddjeri, N., De Montigny, C., & Blier, P.
- Affiliations
- McGill University (CA)
- Corresponding author
- Haddjeri, Nasser
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-02
- Volume
- 120
- Issue
- 5
- Pages
- 865-875
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1564533
- OpenAlex
- W1965641144
- Cited by
- 164
- References
- 76
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 7 · 2016: 2 · 2015: 3 · 2014: 10 · 2013: 4 · 2012: 7
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council Canada
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
- Keywords
- locus coeruleus, noradrenergic neurons, serotonin, WAY-100635, 5-HT1A receptor, neuronal firing, CA3 pyramidal cells, dorsal hippocampus, 5,7-dihydroxytryptamine lesion, 5-HT receptor subtypes
- MeSH terms
- Animals, Hippocampus, Iontophoresis, Locus Coeruleus, Male, Neurons, Norepinephrine, Piperazines, Pyridines, Serotonin, Serotonin Antagonists, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review